Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Anesiva Commences Phase 3 Clinical Study of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Mar 28, 2007
|
13.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., March 28, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that it has begun enrolling adult patients in a Phase 3 clinical study of Zingo(TM), the company's fast-acting, local anesthetic to treat pain associated with peripheral venous access procedures. The trial is de...
|
|
|
Anesiva to Present at Lehman Brothers Global Healthcare Conference on March 21, 2007
Mar 15, 2007
|
10.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., March 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that John P. McLaughlin, the company's chief executive officer, will present at the Lehman Brothers Tenth Annual Global Healthcare Conference in Miami Beach, Florida on March 21, 2007 at 9:30 am Eastern Time.
...
|
|
|
Anesiva to Present at Oppenheimer Pain Management Investor Conference on March 6, 2007
Mar 1, 2007
|
10.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., March 1, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that John P. McLaughlin, the company's chief executive officer, will present at the Oppenheimer Pain Management Investor Conference on March 6, 2007 at 2:10 p.m. EST in New York City.
To access the live webca...
|
|
|
Anesiva Presents Data On Pain Drug, 4975, Demonstrating Pain Reduction For Up To Two Weeks After Knee Replacement Surgeries
Feb 9, 2007
|
15.5 KB
|
| |
SOUTH SAN FRANCISCO, Feb 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) presented positive, clinical data from a Phase 2 clinical trial in total knee replacement surgeries with drug candidate, 4975, the company's novel, long-acting, non-opioid drug candidate being developed for site-specific, moderate-to-sev...
|
|
|
Anesiva Announces Fourth Quarter and Year-End 2006 Financial Results
Feb 8, 2007
|
15.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 08, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today financial results for the fourth quarter and year ended December 31, 2006.
"2006 was a tremendous year for Anesiva with the filing of our New Drug Application (NDA) for Zingo(TM) and the robust data observed i...
|
|
|
Click here to download our most recent fact sheet.